Neo Ivy Capital Management »

Supernus Pharmaceuticals shares owned by Neo Ivy Capital Management

Quarter-by-quarter ownership of Supernus Pharmaceuticals (SUPN) shares owned by Neo Ivy Capital Management from 13F filings

Historical chart of Neo Ivy Capital Management investment in Supernus Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Supernus Pharmaceuticals held by Neo Ivy Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Supernus Pharmaceuticals by Neo Ivy Capital Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $11k 220 47.79

More positions owned by Neo Ivy Capital Management

NVIDIA Corporation (NVDA)
Ford Motor Company (F)
Centene Corporation (CNC)
Ceridian Hcm Hldg (DAY)
Comcast Corp-a Cl A (CMCSA)
Palantir Techn-a Cl A (PLTR)
Southern Company (SO)
Hanesbrands (HBI)
Pitney Bowes (PBI)
Confluent Inc-a Class A Com (CFLT)
Cadence Bank (CADE)
Unity Software (U)
UnitedHealth (UNH)
At&t (T)
Hims & Hers Heal Com Cl A (HIMS)

View all positions for Neo Ivy Capital Management

Top funds holding Supernus Pharmaceuticals

BlackRock
Vanguard Group
Dimensional Fund Advisors
Armistice Capital
Macquarie Group
State Street Corporation
Point72 Asset Management
Renaissance Technologies
Citadel Advisors
Geode Capital Management
Stephens Investment Management Group
Loomis, Sayles and
Woodline Partners
Goldman Sachs Group
Jennifer Ranahan

View all funds holding Supernus Pharmaceuticals